Drug Channels

FEBRUARY 21, 2023

Pharmacies and Pharmacy Benefit Managers. Those who preorder will receive a download link before March 14. CLICK HERE to download a free pre-publication overview (including key industry trends, the Table of Contents, and a List of Exhibits). Download a free report overview for more details on the new sections and content.

Pharmacy 97

Pharmacy Specialty Pharmacies Licensing Licensing 97

Drug Channels

MARCH 4, 2025

for an exclusive deep dive into the latest trends, data, and strategies shaping the pharmacy benefit management (PBM) industry. Pharmacies and Pharmacy Benefit Managers , Dr. Fein will provide invaluable insights to help you and your team stay informed about this rapidly evolving market. Fein, Ph.D.,

Pharmacy 98

Pharmacy Specialty Pharmacies Marketing Drugs 98

Drug Channels

OCTOBER 23, 2023

With regulation and policy changes, specifically surrounding the DCSCA, IRA and serialization, the loss of exclusivity wave, adoption of low-WAC products affecting GTN and the rise of alternative distribution models, there has never been a more important time for industry to unite. What can you expect?

Pharmacy 75

Pharmacy Biosimilars Marketing Production 75

Drug Channels

FEBRUARY 22, 2022

Pharmacies and Pharmacy Benefit Managers. Those who preorder will receive a download link before March 15. CLICK HERE to download a free pre-publication overview. This 2022 edition addresses COVID-19 and its ongoing impact on the pharmacy and PBM industries. Download a free report overview for more details.

Pharmacy 96

Pharmacy Specialty Pharmacies Biosimilars Licensing 96

Agency IQ

JULY 12, 2024

Regulation (EU) 2022/123 , which called for a “reinforced role for EMA in crisis preparedness and management for medicinal products and medical devices,” expanded EMA’s mandate to monitor and mitigate shortages at the E.U. Most recently, Regulation (EU) 2022/123 requires the EMA to monitor shortages that could lead to crisis situations.

Regulations 40

Regulations Production Packaging FDA 40

Codon

FEBRUARY 13, 2024

Regulators traditionally want to see a single, stable, well-characterized drug before giving the green light for it to be tested in a clinical trial, not dozens of different viruses; let alone ones that are best found in unappealing places like sewage , hospital waste, or bird poop. Phage therapies are sold at a pharmacy in Georgia.

Therapies 131

Therapies Virus DNA Clinical Trials 131

The Pharma Data

JANUARY 17, 2021

And the company supplies tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care. View original content to download multimedia: [link]. SOURCE Grifols, SA. Company Codes: NASDAQ-NMS:GRFS, SpanishCats:GRF, OTC-PINK:GIKLY, SpanishCats:GRF.P.

Clinical Trials 52

Clinical Trials Treatment Trials Virus 52